ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Recombinant Antibody Fragments for Immunotherapy of Parkinson's Disease.

Karen Manoutcharian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.